Skip to main content
. 2020 Jun 16;10:322. doi: 10.3389/fcimb.2020.00322
Disease severity Moderate P* Severe (severe + critically severe) P**
COVID-19 n = 140 SN-CAP n = 97 COVID-19n = 164 SN-CAP n = 41
White blood cell count, x109/L 5.72 (2.03) 7.67 (3.1) <0.01 7.11 (3.58) 9.2 (5.85) <0.01
Lymphocyte count, x109/L 1.44 (0.6) 1.27 (0.65) 0.04 0.96 (0.75) 1.06 (0.75) 0.43
Lymphocyte ratio, % 26.59 (10.17) 18 (0.95) <0.01 15.39 (9.82) 13.85 (10.3) 0.37
Neutrophil count, x109/L 3.77 (1.82) 5.62 (2.74) <0.01 5.73 (3.55) 7.71 (5.99) <0.01
Platelet count, x109/L 223 (76) 187 (81) 0.01 188 (86) 203 (90) 0.33
C-Reactive protein, mg/L 16 (30) 34.88 (43.25) <0.01 67.75 (73.93) 53.4 (63.1) 0.26
NLR, % 3.1 (2.41) 6.42 (8.14) <0.01 11.66 (27.66) 13.6 (19) 0.67
PLR, % 181 (97) 193 (120) 0.42 262 (196) 309 (248) 0.2

P-value indicates differences between COVID-19 and SN-CAP; P* indicates differences of moderate pneumonia between COVID-19 and SN-CAP; P** indicates differences between COVID-19 severe + critically severe group and SN-CAP severe group.

P < 0.05 was considered statistically significant.